IGC Pharma’s Advisor and Inventor of Drug Candidate TGR-63 Receives Award - IGC Pharma, INC.

Press

Releases

June 5, 2023

IGC Pharma’s Advisor and Inventor of Drug Candidate TGR-63 Receives Award

Related Posts

IGC Pharma Strengthens Regulatory Readiness as Phase 2 CALMA Alzheimer’s Trial Approaches Enrollment Closure and Q4 Topline Readout

August 11, 2026

IGC Pharma Evaluates Potential Recovery Options as Federal Jury Verdict Brings Renewed Attention to 2018 IGC Short Campaign

July 29, 2026

IGC Pharma to Showcase AI Portfolio at AAIC 2026, Including AHA Platform That Reduced Alzheimer’s Data Harmonization Time by 90% in Representative Workflow

July 9, 2026

CEO Update

IGC Pharma Strengthens Regulatory Readiness as Phase 2 CALMA Alzheimer’s Trial Approaches Enrollment Closure and Q4 Topline Readout

August 11, 2026

IGC Pharma Evaluates Potential Recovery Options as Federal Jury Verdict Brings Renewed Attention to 2018 IGC Short Campaign

July 29, 2026